Skip to main content
KTTA
NASDAQ Life Sciences

FDA Grants Fast Track Designation to Pasithea's PAS-004 for Neurofibromatosis Type 1 Treatment

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.765
Mkt Cap
$17.129M
52W Low
$0.281
52W High
$3.79
52W Position info
172% above low
Off High info
80% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

KTTA has more than doubled off its 52-week low of $0.281.

Summary

Pasithea Therapeutics announced that the FDA has granted Fast Track designation to its drug candidate, PAS-004, for the treatment of Neurofibromatosis Type 1 (NF1) associated Plexiform Neurofibromas (PN). This positive regulatory milestone follows a recent news report of significant net and operating losses for the company. Fast Track designation is crucial for a clinical-stage biotech like Pasithea, as it facilitates expedited development and review, including more frequent FDA interactions and potential eligibility for accelerated approval or priority review. This development significantly de-risks the drug's path to market and is a material positive catalyst for the company, especially given its small market capitalization. Investors will now watch for updates on the ongoing Phase 1/1b clinical trial for PAS-004.

At the time of this announcement, KTTA was trading at $0.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.1M. The 52-week trading range was $0.28 to $3.79. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

KTTA - Latest Insights

KTTA
Nov 03, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3591
Real-time Price: $0.5383 info
Change: +$0.1792 (+50%) info
Market Cap: $17.776M info
KTTA
Sep 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.550
Real-time Price: $0.5383 info
Change: -$0.0117 (-2%) info
Market Cap: $17.776M info
KTTA
Sep 09, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5697
Real-time Price: $0.5383 info
Change: -$0.0314 (-6%) info
Market Cap: $17.776M info
KTTA
Aug 21, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.490
Real-time Price: $0.5383 info
Change: +$0.0483 (+10%) info
Market Cap: $17.776M info
KTTA
Jul 29, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.4231
Real-time Price: $0.5383 info
Change: +$0.1152 (+27%) info
Market Cap: $17.776M info